Accelerating a New Era of Genetic Medicine for Neuromuscular Disease
About Us
Enabling next-generation genetic medicine.
Kinea Bio was founded in 2020 by highly-respected scientific leaders in the neuromuscular disease space with a history of bench-to-bedside innovations.